Abstract:Abstract Background Cancer stem cells (CSCs) have been recognized as an important drug target, however, the underlying mechanisms have not been fully understood. SKP1 is a traditional drug target for cancer therapy, while, whether SKP1 promotes colorectal cancer (CRC) stem cells (CRC-SCs) and the underlying mechanisms have remained elusive. Methods Human CRC cell lines and primary human CRC cells were used in this study. Gene manipulation was performed by lentivirus system. The mRNA and protein levels of target genes were examined by qRT-PCR and western blot. The sphere-forming and in vitro migration capacities were determined by sphere formation and transwell assay. The self-renewal was determined by limiting dilution assay. The tumorigenicity and metastasis of cancer cells were examined by xenograft model. The promoter activity was examined by luciferase reporter assay. Nuclear run-on and Chromatin immunoprecipitation-PCR (ChIP-PCR) assay were employed to examine the transcription and protein-DNA interaction. Co-immunoprecipitation assay was used to test protein–protein interaction. The relationship between gene expression and survival was analyzed by Kaplan–meier analysis. The correlation between two genes was analyzed by Spearman analysis. Data are represented as mean ± SD and the significance was determined by Student’s t test. Results SKP1 was upregulated in CRC-SCs and predicted poor prognosis of colon cancer patients. Overexpression of SKP1 promoted the stemness of CRC cells reflected by increased sphere-forming, migration and self-renewal capacities as well as the expression of CSCs markers. In contrast, SKP1 depletion produced the opposite effects. SKP1 strengthened YAP activity and knockdown of YAP abolished the effect of SKP1 on the stemness of CRC cells. SKP1 suppressed RASSF1 at both mRNA and protein level. Overexpression of RASSF1 abolished the effect of SKP1 on YAP activity and CRC stemness. Conclusion Our results demonstrated that SKP1 suppresses RASSF1 at both mRNA and protein level, attenuates Hippo signaling, activates YAP, and thereby promoting the stemness of CRC cells.

Downregulation of Siah1 Promotes Colorectal Cancer Cell Proliferation and Migration by Regulating AKT and YAP Ubiquitylation and Proteasome Degradation.

Zic1 Is Downregulated Through Promoter Hypermethylation, And Functions As A Tumor Suppressor Gene In Colorectal Cancer

SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.

SMC1 promotes proliferation and inhibits apoptosis through the NF‑κB signaling pathway in colorectal cancer.

SKP1 promotes YAP-mediated colorectal cancer stemness via suppressing RASSF1

The Expression of Siah1 is Downregulated and Associated with Bim and Apoptosis in Human Breast Cancer Tissues and Cells

Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer

Ubiquitin ligase Siah1 promotes the migration and invasion of human glioma cells by regulating HIF-1α signaling under hypoxia.

MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling

ZMIZ1 Regulates Proliferation, Autophagy and Apoptosis of Colon Cancer Cells by Mediating Ubiquitin–Proteasome Degradation of SIRT1

SIAH1 Facilitates the Migration and Invasion of Gastric Cancer Cells Through Promoting the Ubiquitination and Degradation of RECK

Long Non-Coding RNA IQCJ-SCHIP1 Antisense RNA 1 is Downregulated in Colorectal Cancer and Inhibits Cell Proliferation.

SNTB1 regulates colorectal cancer cell proliferation and metastasis through YAP1 and the WNT/β-catenin pathway

High Levels of SIRT1 Expression Enhance Tumorigenesis and Associate with a Poor Prognosis of Colorectal Carcinoma Patients

Downregulation of DUSP9 Promotes Tumor Progression and Contributes to Poor Prognosis in Human Colorectal Cancer

Inhibitor of DNA binding 1 (Id1) mediates stemness of colorectal cancer cells through the Id1-c-Myc-PLAC8 axis via the Wnt/β-catenin and Shh signaling pathways.

Inhibitor Of Dna Binding1 (Id1) Mediates Stemness Of Colorectal Cancer Cells Through The Id1-C-Myc-Plac8 Axis Via The Wnt/Beta-Catenin And Shh Signaling Pathways

SIK1 suppresses colorectal cancer metastasis and chemoresistance via the TGF-β signaling pathway

USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer

Apolipoprotein C1 (APOC1) Promotes Tumor Progression Via MAPK Signaling Pathways in Colorectal Cancer.

The Sodium Channel Subunit SCNN1B Suppresses Colorectal Cancer Via Suppression of Active C-Raf and MAPK Signaling Cascade